Please login to the form below

Not currently logged in
Email:
Password:

Norton Healthcare

This page shows the latest Norton Healthcare news and features for those working in and with pharma, biotech and healthcare.

GSK accused of delaying generic Seroxat in UK

GSK accused of delaying generic Seroxat in UK

market. The OFT, which is the government department responsible for protecting consumers, said GSK infringed competition law by making “substantial payments” to Alpharma, Generics (UK) and Norton Healthcare to delay plans ... These payments were part

Latest news

  • NHS news in brief

    Our weekly round of NHS and healthcare stories. Drug firm execs face court over NHS fraud. ... The companies have been named as: Kent Pharmaceuticals, Norton Healthcare, the Goldshield Group, Generics UK, Ranbaxy Laboratories UK Unit, and Regent-GM

  • Sandoz in fraud probe

    Six companies were named as part of the initial investigation: Generics UK, Kent Pharmaceuticals, Regent-GM Laboratories, Goldshield, Norton Healthcare and Ranbaxy (UK).

  • Nine drug executives to be charged in generics fraud probe

    At the time, other companies named by the SFO as being under investigation were Generics UK (a unit of Merck KGaA), Kent Pharmaceuticals, Regent-GM Laboratories, Norton Healthcare (a subsidiary of

  • AZ defiant after Symbicort patent revoked

    The European Patent Office has upheld an appeal by two generic drug manufactures, Norton Healthcare and Generics UK, and revoked a patent for Symbicort. ... The European Patent Office (EPO) has upheld an appeal by two generic drug manufactures, Norton

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics